CSL is interested in research in the broader area of autoimmunity, with a focus on autoantibody, complement and T cell‑mediated diseases. The focus of this search is on removing or downmodulating the autoimmune component causing disease, while simultaneously preserving protective immunity.
Approaches of Particular Interest
- Antibody‑based Therapeutics
- Bi‑specific (T-cell engaging) Approaches
- Antibody‑Drug Conjugates
- Biologics
- Tolerance Induction
- Cell and Gene Therapies
Development Stage
- Opportunities at the levels of basic through to late pre‑clinical...